Tasfygo (Tasurgratinib)
Japanese prescription-medicine information record for Tasfygo (Tasurgratinib), organized with source context and product-identification fields. This record is informational and does not provide prescribing or treatment guidance.
01 — PRODUCT OVERVIEW
Known product facts.
- Generic name
- Tasurgratinib
- Strength
- 35 mg
- Dosage form
- Tablet
- Package
- Confirmed on inquiry
- Therapeutic area
- Oncology & Hematology
- Classification
- Prescription medicine
02 — SOURCE & VERIFICATION
Keep the source visible.
Publication records keep source provenance and verification metadata. Secondary sources can support discovery, but production publication should be checked against official manufacturer or Japanese regulatory information.
03 — MEDICAL INFORMATION NOTICE
Information, not prescribing.
This page is for professional informational reference only. It does not constitute diagnosis, treatment, prescribing or dosing advice. Always refer to current approved product information, official safety communications and qualified healthcare professionals for medical decisions.